COREG Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Coreg, and when can generic versions of Coreg launch?

Coreg is a drug marketed by Waylis Therap and is included in two NDAs. There is one patent protecting this drug.

The generic ingredient in COREG is carvedilol phosphate. There are thirty-seven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the carvedilol phosphate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Coreg

A generic version of COREG was approved as carvedilol phosphate by SUN PHARM INDUSTRIES on October 25^th, 2017.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for COREG?
What are the global sales for COREG?
What is Average Wholesale Price for COREG?

Summary for COREG

US Patents:	0
Applicants:	1
NDAs:	2
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	145
Patent Applications:	4,484
Drug Prices:	Drug price information for COREG
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for COREG
What excipients (inactive ingredients) are in COREG?	COREG excipients list
DailyMed Link:	COREG at DailyMed

Drug patent expirations by year for COREG

Pharmacology for COREG

Drug Class	alpha-Adrenergic Blocker beta-Adrenergic Blocker
Mechanism of Action	Adrenergic alpha-Antagonists Adrenergic beta1-Antagonists Adrenergic beta2-Antagonists

US Patents and Regulatory Information for COREG

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Waylis Therap	COREG	carvedilol	TABLET;ORAL	020297-004	May 29, 1997	AB	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Waylis Therap	COREG CR	carvedilol phosphate	CAPSULE, EXTENDED RELEASE;ORAL	022012-003	Oct 20, 2006	AB	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up			Y	⤷ Sign Up
Waylis Therap	COREG	carvedilol	TABLET;ORAL	020297-001	Sep 14, 1995	AB	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Waylis Therap	COREG CR	carvedilol phosphate	CAPSULE, EXTENDED RELEASE;ORAL	022012-004	Oct 20, 2006	AB	RX	Yes	No	⤷ Sign Up	⤷ Sign Up			Y	⤷ Sign Up
Waylis Therap	COREG	carvedilol	TABLET;ORAL	020297-003	Sep 14, 1995	AB	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Waylis Therap	COREG	carvedilol	TABLET;ORAL	020297-002	Sep 14, 1995	AB	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for COREG

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Waylis Therap	COREG	carvedilol	TABLET;ORAL	020297-001	Sep 14, 1995	⤷ Sign Up	⤷ Sign Up
Waylis Therap	COREG	carvedilol	TABLET;ORAL	020297-001	Sep 14, 1995	⤷ Sign Up	⤷ Sign Up
Waylis Therap	COREG	carvedilol	TABLET;ORAL	020297-002	Sep 14, 1995	⤷ Sign Up	⤷ Sign Up
Waylis Therap	COREG	carvedilol	TABLET;ORAL	020297-004	May 29, 1997	⤷ Sign Up	⤷ Sign Up
Waylis Therap	COREG	carvedilol	TABLET;ORAL	020297-004	May 29, 1997	⤷ Sign Up	⤷ Sign Up
Waylis Therap	COREG	carvedilol	TABLET;ORAL	020297-003	Sep 14, 1995	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for COREG

See the table below for patents covering COREG around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
German Democratic Republic	143607	VERFAHREN ZUR HERSTELLUNG NEUER CARBAZOLYL-(4)-OXY-PROPANOLAMIN-DERIVATE	⤷ Sign Up
South Africa	9600994		⤷ Sign Up
Canada	2212548	UTILISATION DE COMPOSES DE CARBAZOLE POUR LE TRAITEMENT DE L'INSUFFISANCE CARDIAQUE CONGESTIVE (USE OF CARBAZOLE COMPOUNDS FOR THE TREATMENT OF CONGESTIVE HEART FAILURE)	⤷ Sign Up
Brazil	9607111		⤷ Sign Up
European Patent Office	0808162	UTILISATION DE COMPOSES DE CARBAZOLE POUR LA MANUFACTURE D'UN MEDICAMENT DESTINE AU TRAITEMENT DE L'INSUFFISANCE CARDIAQUE CONGESTIVE (USE OF CARBAZOLE COMPOUNDS FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF CONGESTIVE HEART FAILURE)	⤷ Sign Up
Czechoslovakia	9104200		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for COREG

Pharmacology for COREG

Make Better Decisions: Try a trial or see plans & pricing